CO5271663A1 - IL-8 RECEIVER ANTAGONISTS - Google Patents

IL-8 RECEIVER ANTAGONISTS

Info

Publication number
CO5271663A1
CO5271663A1 CO00084288A CO00084288A CO5271663A1 CO 5271663 A1 CO5271663 A1 CO 5271663A1 CO 00084288 A CO00084288 A CO 00084288A CO 00084288 A CO00084288 A CO 00084288A CO 5271663 A1 CO5271663 A1 CO 5271663A1
Authority
CO
Colombia
Prior art keywords
alkyl
cr8r8
aryl
heterocyclyl
heteroaryl
Prior art date
Application number
CO00084288A
Other languages
Spanish (es)
Inventor
Katherine Louisa Widowson
Mccleland Brent
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5271663A1 publication Critical patent/CO5271663A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Un compuesto de fórmula (I) <EMI FILE="00084288_1" ID="1" IMF=JPEG >dondeR representa R6, C(O)ORa´, CORa´, o S(O)2Ra´,A representa heteroarilo, heterociclilo, arilo o un enlace covalente; n representa un número entero de 1 a 8; Ra´ es un grupo alquilo, arilo, aril-alquilo C1-4, heteroarilo, heteroaril-alquilo C1-4, hererociclilo o heterociclil-alquilo C1-4, pudiendo estar todos ellos opcionalmente sustituidos;m es un número entero que tiene un valor de 1 a 3;mAND#39 es 0, o un número entero que tiene un valor de 1 ó 2; nAND#39 es un número entero que tiene un valor de 1 a 3, q es 0, o un número entero que tiene un valor de 1 a 10; t es 0 o un número entero que tiene un valor de 1 ó 2; s es un número entero que tiene un valor de 1 a 3,R1 independientemente, se selecciona a partir de hidrógeno, halógeno, nitro, ciano, alquilo C1-10, alquilo C1-10 sustituido con halógeno, alquenilo C2-10, alcoxi C1-10, alcoxi C1-10 sustituido con halógeno, azida, S(O)tR4, (CR8R8)qS(O)tR4, hidroxi, alquilo C1-4 sustituido con hidroxi, arilo, aril-alquilo C1-4, aril-alquenilo C2-10, ariloxi, aril-alquil C1-4-oxi, heteroarilo, heteroarilalquilo, heteroaril-alquenilo C2-10, heteroaril-alquil C1-4-oxi, heterociclilo, heterociclil-alquilo C1-4, heterociclil-alquil C1-4-oxi, heterociclil-alquenilo C2-10, (CR8R8)qNR4R5, (CR8R8)qC(O)NR4R5, alquenil C2-10-C(O)NR4R5, (CR8R8)qC(O)NR4R10, S(O)3R8, (CR8R8)qC(O)R11, alquenil C2-10-C(O)R11, alquenil C2-10-C(O)OR11, (CR8R8)qC(O)OR11, (CR8R8)qOC(O)OR11, (CR8R8)qNR4C(O)R11, (CR8R8)qC(NR4)NR4R5, (CR8R8)qNR4C(NR5)R11, (CR8R8)qNHS(O)tR13, (CR8R8)qS(O)tNR4R5, o dos restos R1 juntos pueden formar O-(CH2)sO o un anillo saturado o insaturado de 5 a 6 miembros y donde los restos alquilo, arilo, arilalquilo, heteroarilo, heterociclo pueden estar opcionalmente sustituidos; R4 y R5 son independientemente hidrógeno, alquilo C1-4 opcionalmente sustituido, arilo opcionalmente sustituido, aril-alquilo C1-4 opcionalmente sustituido, heteroarilo opcionalmente sustituido, heteroaril-alquilo C1-4 opcionalmente sustituido, heterociclilo, ...A compound of formula (I) <EMI FILE = "00084288_1" ID = "1" MFI = JPEG> where R represents R6, C (O) ORa´, CORa´, or S (O) 2Ra´, A represents heteroaryl, heterocyclyl , aryl or a covalent bond; n represents an integer from 1 to 8; Ra 'is an alkyl, aryl, aryl-C 1-4 alkyl, heteroaryl, heteroaryl-C 1-4 alkyl, heterocyclyl or heterocyclyl-C 1-4 alkyl group, all of which may be optionally substituted; m is an integer having a value from 1 to 3; mAND # 39 is 0, or an integer that has a value of 1 or 2; nAND # 39 is an integer that has a value of 1 to 3, q is 0, or an integer that has a value of 1 to 10; t is 0 or an integer that has a value of 1 or 2; s is an integer having a value of 1 to 3, R1 independently, is selected from hydrogen, halogen, nitro, cyano, C1-10 alkyl, halogen substituted C1-10 alkyl, C2-10 alkenyl, C1 alkoxy -10, C1-10 alkoxy substituted with halogen, azide, S (O) tR4, (CR8R8) qS (O) tR4, hydroxy, C1-4 alkyl substituted with hydroxy, aryl, aryl-C1-4 alkyl, aryl-alkenyl C2-10, aryloxy, arylC 1-4 alkyl-oxy, heteroaryl, heteroarylalkyl, C2-10 heteroaryl-alkenyl, heteroarylC 1-4 alkyl-oxy, heterocyclyl, heterocyclyl-C 1-4 alkyl, heterocyclyl-C 1-4 alkyl -oxy, C2-10 heterocyclyl-alkenyl, (CR8R8) qNR4R5, (CR8R8) qC (O) NR4R5, C2-10-alkenyl (O) NR4R5, (CR8R8) qC (O) NR4R10, S (O) 3R8, (CR8R8) qC (O) R11, C2-10-C alkenyl (O) R11, C2-10-C alkenyl (O) OR11, (CR8R8) qC (O) OR11, (CR8R8) qOC (O) OR11, ( CR8R8) qNR4C (O) R11, (CR8R8) qC (NR4) NR4R5, (CR8R8) qNR4C (NR5) R11, (CR8R8) qNHS (O) tR13, (CR8R8) qS (O) tNR4R5, or two R1 moieties together can form O- (CH2) sO or a saturated or unsaturated ring of 5 to 6 members ros and where the alkyl, aryl, arylalkyl, heteroaryl, heterocycle moieties may be optionally substituted; R4 and R5 are independently hydrogen, optionally substituted C1-4 alkyl, optionally substituted aryl, optionally substituted aryl-C1-4 alkyl, optionally substituted heteroaryl, optionally substituted heteroaryl-C1-4 alkyl, heterocyclyl, ...

CO00084288A 1999-11-09 2000-11-07 IL-8 RECEIVER ANTAGONISTS CO5271663A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16435099P 1999-11-09 1999-11-09

Publications (1)

Publication Number Publication Date
CO5271663A1 true CO5271663A1 (en) 2003-04-30

Family

ID=22594097

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00084288A CO5271663A1 (en) 1999-11-09 2000-11-07 IL-8 RECEIVER ANTAGONISTS

Country Status (5)

Country Link
EP (1) EP1237548A4 (en)
JP (1) JP2003513919A (en)
AU (1) AU1588501A (en)
CO (1) CO5271663A1 (en)
WO (1) WO2001034141A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp Il-8 receptor antagonists
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists

Also Published As

Publication number Publication date
JP2003513919A (en) 2003-04-15
EP1237548A1 (en) 2002-09-11
AU1588501A (en) 2001-06-06
EP1237548A4 (en) 2003-07-23
WO2001034141A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
CO5390047A1 (en) DERIVATIVES OF UK-2A
CO5261539A1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
CO4890843A1 (en) IL-8 RECEPTORS ANTAGONISTS OF IL-8
AR015425A1 (en) BENZOTIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE FOR PREPARATION, INTERMEDIARY COMPOUNDS AND PROCEDURE FOR PREPARATION
HUP0000467A2 (en) Il-8 receptor antagonists
CO5280059A1 (en) DERIVATIVES OF 2-OX-1-PIRROLIDINA, PROCEWO TO PREPARE THEM AND ITS APPLICATIONS
CO5160302A1 (en) AP2 INHIBITORS OF BIFENILOS CONTAINING HETEROCICLIC COMPOUNDS AND METHOD
CO5140093A1 (en) MODIFIED EPOTILONES C 21
AR032398A1 (en) SULFONAMIDE ESCUARAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE OF THIS COMPOUND TO PREPARE SUCH COMPOSITION
CO5031286A1 (en) CIANO GUANADINA COMPOUNDS AS ANTAGONISTS OF IL-8 RECEPTORS AND PREPARATION METHOD
CO5170518A1 (en) N- (BENZOCICLOALQUILO) COMPOUNDS DERIVED FROM AMINO ARALIFATICOS
CY1110025T1 (en) ISOXAZOLINE PRODUCERS AND THEIR USE OF HERBICIDES
CO5280079A1 (en) NEW COMPOUNDS
CO5200760A1 (en) RECEIVER ANTAGONISTS OF IL-8 CEPTOR IL-8
AR033803A1 (en) DIANILINO ESCUARANO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM, AND THE USE OF THE SAME IN THE MANUFACTURE OF MEDICINES TO TREAT CHEMIOQUINE MEDIUM-RELATED DISEASES
CO5190696A1 (en) ANTAGONISTS OF IL-8 RECEIVERS
BR0314810A (en) Fiber Reinforced Cement Material
CO5170514A1 (en) ANTAGONISTS OF IL-8 RECEIVERS RECEIVERS OF IL-8
DK1189900T3 (en) Heterocyclic aminopyrrolidine derivatives as melatonergic drugs
AR008331A1 (en) ANTAGONIST COMPOUNDS OF AN IL-8 RECEPTOR, USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES, PROCEDURE FOR THEIR OBTAINING, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
CO5271663A1 (en) IL-8 RECEIVER ANTAGONISTS
CO5170528A1 (en) ANTAGONISTS OF IL-8 RECEIVERS RECEIVERS OF IL-8
CO5400148A1 (en) DERIVATIVES OF PIRAZOLES THAT ARE ANTAGONISTS OF CCK-1
CO5170526A1 (en) NEW USEFUL CYCLING GUANIDINE COMPOUNDS AS ANTAGONIS TAS OF THE IL-8 RECEIVER
CO5271703A1 (en) CHEMICAL COMPOUNDS

Legal Events

Date Code Title Description
FA Application withdrawn